New Developments

International coverage of treatments and trials, with the ability to zoom in on countries we cover. From approved options to compassionate access.

Live Breakthroughs Feed

All countriesUnited StatesCanadaUnited KingdomJapanChinaAustraliaSwitzerlandEuropean UnionNewestPatient StoriesFDA Approved ×
FDA ApprovedUnited StatesJapan

New Oral Medicine to Help Prevent COVID-19 After Exposure

Xocova / Zokovea (ensitrelvir) — oral COVID-19 post-exposure prophylaxis

The first FDA-labelled oral option for COVID-19 post-exposure prophylaxis (PEP). On 29 May 2026 the FDA approved Xocova (ensitrelvir) tablets…

The first FDA-labelled oral option for COVID-19 post-exposure prophylaxis (PEP). On 29 May 2026…